Omnitrope and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is reported as a side effect among people who take Omnitrope (somatropin recombinant), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Claritin, and have Hypopituitarism.

The phase IV clinical study analyzes which people have Stroke when taking Omnitrope. It is created by eHealthMe based on reports of 8,562 people who have side effects when taking Omnitrope from the FDA, and is updated regularly.

What is Omnitrope?

Omnitrope has active ingredients of somatropin recombinant. It is often used in growth hormone deficiency. eHealthMe is studying from 8,582 Omnitrope users. Check the latest studies of Omnitrope.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,382 drugs and 3,011 conditions by eHealthMe. Check the latest studies of Stroke.

On Dec, 07, 2025

8,562 people reported to have side effects when taking Omnitrope.
Among them, 33 people (0.39%) have Stroke.

Among these 33 people:

How long have people been on Omnitrope when they have Stroke? *

What is the gender of people who have Stroke when taking Omnitrope? *

female: 43.75 %
male: 56.25 %

What is the age of people who have Stroke when taking Omnitrope? *

What are other drugs people take besides Omnitrope? *

What are other side effects people have besides Stroke? *

Injection Site Pain: 2 people, 6.06%
Lower Respiratory Tract Infection: 2 people, 6.06%
Injection Site Erythema (redness at injection site): 2 people, 6.06%
Injection Site Haemorrhage (bleeding from injection site): 2 people, 6.06%
Injection Site Mass: 2 people, 6.06%
Joint Pain: 2 people, 6.06%
Joint Swelling: 2 people, 6.06%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 6.06%
The Flu (the flu is caused by an influenza virus): 2 people, 6.06%
Injection Site Bruising: 2 people, 6.06%

What are the existing conditions these people have? *

Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 5 people, 15.15%
Pituitary Tumor Benign: 1 person, 3.03%
Hyperpituitarism (excessive activity of the pituitary gland): 1 person, 3.03%
Failure To Thrive (inadequate weight gain and physical growth in children): 1 person, 3.03%
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord): 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Omnitrope and have Stroke?

- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Omnitrope:

Omnitrope (8,582 reports)

Stroke treatments and more:

Stroke (334,631 reports)

Browse all side effects of Omnitrope:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stroke:

Stroke (2,382 drugs)

Browse all the conditions that are associated with Stroke:

Stroke (3,011 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on somatropin recombinant (the active ingredients of Omnitrope) and Omnitrope (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.